What are the active alkaloid components of kratom?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Active Components of Kratom

Kratom contains over 40 alkaloids, with mitragynine and 7-hydroxymitragynine being the two primary psychoactive compounds responsible for its opioid-like and stimulant effects 1, 2.

Primary Active Alkaloids

The main molecular constituents are:

  • Mitragynine: The most abundant alkaloid, typically found at concentrations of 13.9-270 mg/g in commercial products 3. This is the predominant compound responsible for kratom's effects.

  • 7-hydroxymitragynine (7-OH-MG): The second major psychoactive alkaloid, though present in much lower concentrations than mitragynine 4, 2.

Both compounds act as partial agonists at μ-opioid receptors and antagonists at κ- and δ-opioid receptors, with additional effects at adrenergic, serotonergic, and dopaminergic pathways 4, 2. Notably, they lack effects on β-arrestin, which may explain kratom's potentially better tolerability profile compared to classical opioids 4.

Secondary Alkaloids

Beyond the two primary compounds, kratom contains numerous other indole and oxindole alkaloids that contribute to its overall pharmacological profile 3:

Major secondary indole alkaloids (quantifiable in commercial products):

  • Paynantheine
  • Speciociliatine
  • Speciogynine
  • Mitraciliatine
  • Isopaynantheine
  • Ajmalicine
  • Corynantheidine

Oxindole alkaloids (present in varying concentrations):

  • Isomitraphylline
  • Isospeciofoleine
  • Speciofoline
  • Corynoxine A and B
  • Corynoxeine
  • Rhynchophylline
  • Mitraphylline

Pharmacokinetic Considerations

Only four alkaloids show significant systemic exposure 8 hours after oral consumption: mitragynine, 7-hydroxymitragynine, speciociliatine, and corynantheidine 5. Paynantheine and speciogynine are detectable only up to 1 hour post-dose, while other alkaloids show minimal to no systemic absorption 5.

Critical Clinical Caveat

The alkaloid profile varies significantly between products and preparation methods 3, 6. Commercial products typically show high mitragynine content (13.9-270 mg/g), while certain plant chemotypes (like US-grown "Rifat" strain) may have elevated speciogynine instead 3. Despite marketing claims about different "strains" having distinct effects, laboratory analyses reveal no significant cross-strain differences in alkaloid content, suggesting effect differences may be influenced more by placebo and marketing narratives than actual chemical composition 6.

Important drug interaction warning: Several kratom alkaloids inhibit CYP2D6 and, to a lesser extent, CYP2C19 and CYP3A4 enzymes 1, 4, creating significant potential for drug-drug interactions in the perioperative and clinical setting.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.